| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |